Sign Up to like & get
recommendations!
1
Published in 2020 at "Primary Care Diabetes"
DOI: 10.1016/j.pcd.2020.05.013
Abstract: Inhibitors of Sodium-Glucose transporter (SGLT-2) are among the newest pharmacotherapeutics to be evaluated for the management of 2019-Coronavirus disease (COVID-19). Few hypotheses like reduced lactatemia, inhibition of Na-H exchanger, reduction of proinflammatory cytokines, augmentation of…
read more here.
Keywords:
sglt inhibitors;
waiting happen;
happen another;
covid miracle ... See more keywords